ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $41,014,000 | +28.2% | 1,291,770 | 0.0% | 0.80% | +26.3% |
| Q3 2014 | $31,984,000 | +9.6% | 1,291,770 | 0.0% | 0.63% | +18.9% |
| Q2 2014 | $29,182,000 | +0.0% | 1,291,770 | +7.7% | 0.53% | +8.3% |
| Q1 2014 | $29,176,000 | +15.7% | 1,199,200 | +18.8% | 0.49% | +15.8% |
| Q4 2013 | $25,220,000 | -46.3% | 1,009,200 | -41.0% | 0.42% | -53.6% |
| Q3 2013 | $46,951,000 | – | 1,709,200 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |